Moreover, FPN1 expression is decreased in multiple cancers, including prostate cancer, ovarian cancer, breast cancer, multiple myeloma (MM) and adrenocortical carcinoma [22–28]. The gene discussed is SLC40A1; the disease is prostate cancer.